New radiation implant shows promise for skin cancer

NCT ID NCT04068155

Recruiting now Disease control Sponsor: Alpha Tau Medical LTD. Source: ClinicalTrials.gov ↗

First seen Jun 18, 2026 · Last updated Jun 18, 2026

Summary

This study tests a new device that delivers a special type of radiation directly into skin tumors. The goal is to see if it can shrink or control the cancer. The study is for adults with certain types of skin cancer, including squamous cell carcinoma and basal cell carcinoma. Participants will receive the treatment and be monitored for tumor response and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU Grenoble Alpes
RECRUITING

Grenoble, 38700, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centre Léon Bérard
RECRUITING

Lyon, 69008, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

basal cell carcinoma carcinosarcoma eyelid neoplasm lentigo maligna melanoma lip cancer skin basal cell carcinoma skin cancer skin neoplasm skin squamous cell carcinoma squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CUTANEOUS METASTASIS CUTANEOUS TUMOR SKIN CANCER